JAC Advance Access originally published online on February 16, 2007
Journal of Antimicrobial Chemotherapy 2007 59(4):786-790; doi:10.1093/jac/dkl562
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
1 Fourth Department of Internal Medicine, Athens University Medical School, University General Hospital ‘ATTIKON’, Athens, Greece 2 Second Department of Intensive Care, Athens University Medical School, University General Hospital ‘ATTIKON’, Athens, Greece
Received 16 September 2006; returned 3 November 2006; revised 18 December 2006; accepted 19 December 2006
* Corresponding author. Tel: +210-5831990; Fax: +210-5326446; E-mail: hgiama{at}ath.forthnet.gr
Objectives: Infections due to multidrug-resistant (MDR) Gram-negative pathogens in the ICU have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this retrospective observational study was to record and present the emergence of colistin-resistant Klebsiella pneumoniae (CRKB) in a Greek ICU.
Methods: In a new university tertiary hospital, the first patients admitted in the ICU were already colonized or infected with MDR pathogens, and this led to frequent colistin use as part of empirical or microbiologically documented therapy. Colistin resistance was defined as MIC >4 mg/L by the Etest method. All CRKB isolated in surveillance cultures or clinical specimens in the ICU during the period 2004–5 were recorded along with patients' characteristics.
Results: Eighteen CRKB were isolated from 13 patients over a 16 month period, representing either colonizing or infective isolates. Patients' mean age was 70 years, with a mean APACHE II score at admission of 22. They all had a long hospitalization (median 69 days) and a long administration of colistin (median 27 days). Colistin-resistant isolates were implicated as pathogens in two bacteraemias, a ventilator-associated pneumonia and two soft tissue infections. Repetitive extragenic palindromic PCR identified six distinct clones, and horizontal transmission was also documented.
Conclusions: Selective pressure due to extensive or inadequate colistin use may lead to the emergence of colistin resistance among K. pneumoniae isolates, jeopardizing treatment options in the ICU, potentially increasing morbidity and mortality of critically ill patients and necessitating prudent use of colistin.
Keywords: polymyxins , microbial resistance , antibiotic consumption , selection pressure
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-Y. Suh, J. S. Son, D. R. Chung, K. R. Peck, K. S. Ko, and J.-H. Song Nonclonal Emergence of Colistin-Resistant Klebsiella pneumoniae Isolates from Blood Samples in South Korea Antimicrob. Agents Chemother., January 1, 2010; 54(1): 560 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Hawkey and A. M. Jones The changing epidemiology of resistance J. Antimicrob. Chemother., September 1, 2009; 64(suppl_1): i3 - i10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sun, A. Negrea, M. Rhen, and D. I. Andersson Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2298 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Souli, P. D. Rekatsina, Z. Chryssouli, I. Galani, H. Giamarellou, and K. Kanellakopoulou Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates? Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2133 - 2135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lee, G. Patel, S. Huprikar, D. P. Calfee, and S. G. Jenkins Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection J. Clin. Microbiol., May 1, 2009; 47(5): 1611 - 1612. [Full Text] [PDF]
|
|
|
|
|
|
A. Poudyal, B. P. Howden, J. M. Bell, W. Gao, R. J. Owen, J. D. Turnidge, R. L. Nation, and J. Li In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae J. Antimicrob. Chemother., December 1, 2008; 62(6): 1311 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Kollef, G. E. Schramm, A. R. Wills, R. M. Reichley, S. T. Micek, and M. H. Kollef Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria Chest, August 1, 2008; 134(2): 281 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Landman, C. Georgescu, D. A. Martin, and J. Quale Polymyxins Revisited Clin. Microbiol. Rev., July 1, 2008; 21(3): 449 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Zavascki, L. Z. Goldani, J. Li, and R. L. Nation Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review J. Antimicrob. Chemother., December 1, 2007; 60(6): 1206 - 1215. [Abstract] [Full Text] [PDF]
|
|